Absence of urine formation. It is usually associated with complete bilateral ureteral (URETER) obstruction, complete lower urinary tract obstruction, or unilateral ureteral obstruction when a solitary kidney is present.
Mercury poisoning, also known as hydrargyria, is a type of metal toxicity caused by exposure to excessive levels of mercury, leading to harmful effects on the nervous system, kidneys, and other organs, often resulting from improper handling or ingestion of mercury-containing substances.
Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.

Frequency and causes of discrepancy between Kt/V and creatinine clearance. (1/116)

This study examines the frequency of discrepancy between Kt/V urea and creatinine clearance (Ccr) measurements in patients on peritoneal dialysis (PD) and the reasons for this discrepancy. DESIGN: Nonrandomized, retrospective data analysis. SETTING: Single PD unit of a university teaching hospital. PATIENTS: All adult patients receiving PD at our center from January 1995 to December 1996. METHODS: Actual (a) and desired (d) body weight (BW) were used to calculate urea volume of distribution (V) and body surface area (BSA). Patients were divided into four groups based upon their total small solute clearances (Kt/V and Ccr, normalized by actual weight) and three additional groups based upon actual/desired (a/d) body weight ratio. An additional analysis was performed for the subset of anuric patients. Data collected for all patients included the following: total Kt, total Ccr, 4-hour dialysate/ plasma (D/P) creatinine, serum albumin concentration, duration of PD, actual body weight, age, and height. RESULTS: Twenty-three percent of the clearance measurements in our study were discrepant, defined as having values for either Kt/V or Ccr (but not both) above the accepted targets of Kt/V > or = 2.0/wk and Ccr > or = 60 L/wk/ 1.73 m2. Patients with both values above target are more likely to have higher residual renal function. Patients who are significantly less than BWd and patients on PD for a longer time are more likely to have adequate Kt/V but not Ccr. Furthermore, patients who are less than 90% or greater than 110% of BWd have markedly different values for Kt/V and Ccr when BWa versus BWd values are used. CONCLUSIONS: Kt/V and Ccr values are frequently discrepant; a number of factors affect these two measurements to varying degrees, including weight, degree of residual renal function, and duration of PD.  (+info)

Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients. (2/116)

OBJECTIVE: To investigate the pharmacokinetic parameters of intermittent intraperitoneal (IP) cefazolin, and recommend a cefazolin dosing regimen in continuous ambulatory peritoneal dialysis (CAPD) patients. DESIGN: Prospective nonrandomized open study. SETTING: CAPD outpatient clinic in Albany, New York. PATIENTS: Seven volunteer CAPD patients without peritonitis. Three of the patients were nonanuric while 4 were anuric. INTERVENTIONS: Cefazolin (15 mg/kg total body weight) was given to each patient during the first peritoneal exchange. Blood and dialysate samples were collected at times 0, 0.5, 1,2,3,6 (end of the first antibiotic-containing dwell), 24, and 48 hours after the administration of IP cefazolin. Urine samples were collected in nonanuric patients over the study period. RESULTS: The mean+/-SD amount of cefazolin dose absorbed from the dialysate after the 6-hour dwell was 69.7%+/-8.0% of the administered dose. The cefazolin absorption rate constant from dialysate to serum was 0.21+/-0.1/hr (absorption half-life 3.5+/-0.8 hr). The mean serum concentrations reached at 24 and 48 hours were 52.4+/-3.7 mg/L and 30.3+/-5.9 mg/L, respectively. The mean dialysate cefazolin concentrations reached at 24 and 48 hours were 15.1+/-3.4 mg/L and 7.9+/-1.4 mg/L, respectively. The cefazolin serum elimination rate constant was 0.02+/-0.01/hr (elimination half-life 31.5+/-8.8 hr). The total cefazolin body clearance was 3.4+/-0.6 ml/min. In the 3 nonanuric patients the mean renal clearance of cefazolin was 0.6+/-0.4 ml/min. The peritoneal clearance of cefazolin was 1.0+/-0.3 mL/min. The systemic volume of distribution of cefazolin was 0.2+/-0.05 L/kg. No statistical difference was detected in pharmacokinetic parameters between anuric and nonanuric patients, although this may be due to the small number of patients in each group. CONCLUSION: A single daily dose of cefazolin dosed at 15 mg/kg actual body weight in CAPD patients is effective in achieving serum concentration levels greater than the minimum inhibitory concentration for sensitive organisms over 48 hours, and dialysate concentration levels over 24 hours. Caution is warranted in extrapolation of dosing recommendations to patients who maintain a significant degree of residual renal function.  (+info)

Peritoneal dialysis adequacy: a model to assess feasibility with various modalities. (3/116)

BACKGROUND: The current standard of adequacy for peritoneal dialysis (PD) is to provide a weekly normalized urea clearance (Kt/V) of 2.0 or more and a creatinine clearance (CCr) of 60 liter/1.73 m2 or more. As native renal function is lost, it is important to determine the effectiveness of the available therapeutic modalities in achieving these goals. METHODS: A model to assess our ability to provide a weekly Kt/Vurea of 2.0 or more and a CCr of 60 liter/1.73 m2 or more to anuric patients undergoing continuous ambulatory PD (CAPD) and automated PD (PD Plus) was developed. The body surface area (BSA) distribution was obtained from 38,768 patients undergoing dialysis during January 1997. The distribution of peritoneal transport rates (PTRs) was obtained from 2531 peritoneal equilibration tests performed during 1996. The weekly Kpt/Vurea was calculated for the various PTR groups and the range of BSA with four PD prescriptions: CAPD 8 liters, CAPD 10 liters, PD Plus 12 liters, and PD Plus 15 liters, using a previously validated kinetic program (PackPD). RESULTS: The predicted percentage of patients capable of achieving the adequacy goals for Kt/V and CCr, respectively, were 24.8 and 11. 2 for CAPD 8 liters, 54.2 and 33.0 for CAPD 10 liters, 77.8 and 54.9 for PD Plus 12 liters, and 93.2 and 72.9 for PD Plus 15 liters. CONCLUSIONS: Most patients can attain the current adequacy standards of therapy with automated PD, but few (less than 25%) can do so with standard CAPD in the absence of residual renal function.  (+info)

The effect of small solute clearances on survival of anuric peritoneal dialysis patients. (4/116)

OBJECTIVE: Primarily, to determine whether peritoneal small solute clearance is related to patient and technique survival among anuric peritoneal dialysis [continuous ambulatory (CAPD) and automated peritoneal dialysis (APD)] patients. A secondary goal was to describe the ability to attain Dialysis Outcomes Quality Initiative (DOQI) targets among anuric patients on peritoneal dialysis. DESIGN: Retrospective cohort study via chart reviews. SETTING: Peritoneal Dialysis Unit of Toronto Hospital (Western Division). PATIENTS: The study included 122 CAPD and APD patients between January 1992 and September 1997, with 24-hour urine volume less than 100 mL, or renal creatinine clearance (CCr) less than 1 mL/minute. Adequacy data were available for 115 patients. OUTCOME MEASURES: Mortality and technique failure (TF). Regression analysis was used to estimate the mortality and TF rate ratios (RR) for peritoneal Kt/V urea (pKt/V) and pCCr, adjusting for age, gender, diabetes, months of follow-up prior to anuria, albumin, transport status, coronary artery disease, cardiovascular disease, and peripheral vascular disease. RESULTS: Fifty seven per cent (51/89) of patients on CAPD and 81% (21/26) on APD had a weekly pKt/V > or = 2 and > or = 2.2, respectively (DOQI targets); whereas only 35% on CAPD (31/89) and 35% (9/26) on APD had a weekly pCCr > or = 60 U1.73 m2 and 66 L/1.73 m2, respectively. Median follow-up times among patients were 16.5 and 19.5 months pre- and postanuria, respectively. Patients with pKt/V > or = 1.85 experienced a strong decrease in patient mortality (RR = 0.54, p= 0.10); the effect was less pronounced for pCCr > or = 50 L/1.73 m2 (RR = 0.63, p = 0.25). No relationship was observed between pKt/V or pCCr and TF. CONCLUSION: Mortality was noticeably less frequent among patients with a pKt/V > or = 1.85 compared with those with a Kt/W < 1.85 (p = 0.10). Given the magnitude of the association, the failure to observe statistical significance relates to the size of the patient cohort. Our results imply that it is, in fact, possible to achieve DOQI targets among anuric patients on peritoneal dialysis.  (+info)

Impact of dialysis adequacy on the mortality and morbidity of anuric Chinese patients receiving continuous ambulatory peritoneal dialysis. (5/116)

Dialysis adequacy has a major impact on the outcome of continuous ambulatory peritoneal dialysis (CAPD) patients. However, most studies on peritoneal dialysis adequacy have focused on patients with significant residual renal function. The present study examined the effect of dialysis adequacy on anuric CAPD patients. A single-center prospective observational study on 140 anuric CAPD patients was performed. These patients were followed for 22.0 +/- 11.9 mo. Dialysis adequacy and nutritional indices, including Kt/V, creatinine clearance (CCr), protein equivalent nitrogen appearance, percentage of lean body mass, and serum albumin level were monitored. Clinical outcomes included actuarial patient survival, technique survival, and duration of hospitalization. In the study population, 64 were male, 36 (25.7%) were diabetic, and 59 (42.1%) were treated with 6 L exchanges per day. The body weight was 59.2 +/- 10.2 kg. Average Kt/V was 1.72 +/- 0.31, and CCr was 43.7 +/- 11.5 L/wk per 1.73m(2). Two-yr patient survival was 68.8%, and technique survival was 61.4%. Multivariate analysis showed that DM, duration of dialysis before enrollment, serum albumin, and index of dialysis adequacy (Kt/V or CCr) were independent factors of both patient survival and technique survival. It was estimated that for two patients who differed only in weekly Kt/V, a 0.1 higher value was associated with a 6% decrease in the RR of death (P: < 0.05; 95% confidence interval, 0.92 to 0.99). Serum albumin and CCr were the only independent factors that predicted hospitalization. It was found that even when there is no residual renal function, higher dialysis dosage is associated with better actuarial patient survival, better technique survival, and shorter hospitalization. Dialysis adequacy has a significant impact on the clinical outcome of CAPD patients, and the beneficial effect is preserved in anuric patients as well as in an ethnic group that has a low overall mortality.  (+info)

Haemodialysis with the biocompatible high permeability AN-69 membrane does not alter plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3. (6/116)

BACKGROUND: Insulin-like growth factor-I (IGF-I) bioactivity has been reported to be decreased in maintenance haemodialysis patients and this may affect their nutritional status. Clearances of IGF-I and its binding proteins (IGFBPs) during haemodialysis sessions using a high permeability biocompatible membrane are unknown. METHODS: Five well nourished, non-diabetic adult patients were studied during one 4-h morning haemodialysis treatment using the high permeability biocompatible AN-69 dialyser. Blood was collected at the arterial and venous ports of the dialyser at 0, 1, 2 and 4 h of dialysis for haematocrit, plasma IGF-I, IGFBP-3 and insulin measurements. IGF-I, IGFBP-3 and insulin concentrations were adjusted for haemoconcentration before comparisons were made. RESULTS: At the beginning of the dialysis session, plasma IGF-I, IGFBP-3 and insulin levels were within the normal range (297 +/- 47 ng/ml (mean+/-SEM), 4.3 +/- 0.6 microg/ml and 11.8 +/- 3.4 microIU/ml, respectively). During the session, insulin tended to be cleared through the dialyser, whereas plasma IGF-I and IGFBP-3 values did not vary significantly. CONCLUSION: Dialysis with the high permeability AN69 membrane did not alter the main blood compounds of the IGF system in well nourished chronic haemodialysis patients, and it is unlikely that the malnutrition frequently observed in such patients would result from alterations of the IGF system during haemodialysis.  (+info)

Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. (7/116)

Podocalyxin is a CD34-related sialomucin that is expressed at high levels by podocytes, and also by mesothelial cells, vascular endothelia, platelets, and hematopoietic stem cells. To elucidate the function of podocalyxin, we generated podocalyxin-deficient (podxl(-/)-) mice by homologous recombination. Null mice exhibit profound defects in kidney development and die within 24 hours of birth with anuric renal failure. Although podocytes are present in the glomeruli of the podxl(-/)- mice, they fail to form foot processes and slit diaphragms and instead exhibit cell--cell junctional complexes (tight and adherens junctions). The corresponding reduction in permeable, glomerular filtration surface area presumably leads to the observed block in urine production. In addition, podxl(-/)- mice frequently display herniation of the gut (omphalocele), suggesting that podocalyxin may be required for retraction of the gut from the umbilical cord during development. Hematopoietic and vascular endothelial cells develop normally in the podocalyxin-deficient mice, possibly through functional compensation by other sialomucins (such as CD34). Our results provide the first example of an essential role for a sialomucin in development and suggest that defects in podocalyxin could play a role in podocyte dysfunction in renal failure and omphalocele in humans.  (+info)

Acid production and base balance in patients on chronic haemodialysis. (8/116)

Acid generation and elimination processes were compared with total base (bicarbonate plus metabolizable anions) turnover in 18 anuric patients undergoing post-dilutional haemofiltration. The study was conducted during the second haemodialysis session of the week by means of a whole-body base balance technique. The results showed that the mean rates of base loss and base gain during dialysis did not differ (i.e. the dialysis base balance approximated to zero). The concurrent mean rate of intestinal base absorption was 66+/-26 mmol/2 days, as calculated from the whole-body balance of the various inorganic cation and anion differences in a metabolic steady state. This level of intestinal base absorption would be capable of neutralizing the 59+/-21 mmol of H(+) ions/2 days that is contributed by sulphuric acid, which is the most important endogenous acid produced in anuric patients. In spite of the fact that intestinal base supply was adequate to neutralize endogenous acid production completely, our patients presented with pre-dialysis non-carbonic acidosis. The depression of plasma bicarbonate levels could not, however, be explained by increased concentrations of the anion gap and organic acids, which were within normal limits both before and after dialysis. We suggest as an alternative hypothesis that this pre-dialysis acidosis may represent an isotonic dilution acidosis that is induced by the ingestion of base-free tap water in order for plasma tonicity to be protected from the accumulation of impermeant dietary solutes, which takes place during the interdialysis period in anuric patients.  (+info)

Anuria is a medical condition characterized by the absence or near-absence of urine output, typically defined as less than 100 milliliters in 24 hours. This occurs when the kidneys are unable to produce urine due to a complete or nearly complete failure of both kidneys' function. Anuria can be caused by various underlying medical conditions such as severe dehydration, kidney damage, obstruction in the urinary tract, or certain medications that affect kidney function. It is considered a serious medical emergency and requires immediate evaluation and treatment to prevent further complications, including potential permanent kidney damage or even death.

Mercury poisoning, also known as hydrargyria or mercurialism, is a type of metal poisoning caused by exposure to mercury or its compounds. It can occur through inhalation, ingestion, or skin absorption. Symptoms may vary but can include sensory impairment (vision, hearing, speech), disturbed sensation and a lack of coordination. The type of symptoms can vary greatly, depending on the type and amount of mercury and the form in which it was taken. Long-term exposure to mercury can lead to serious neurological and kidney problems. It is usually diagnosed through tests that measure the amount of mercury in the body, such as blood or urine tests. Treatment generally involves eliminating the source of mercury exposure, supportive care, and, in some cases, chelation therapy which helps to remove mercury from the body.

Acute kidney injury (AKI), also known as acute renal failure, is a rapid loss of kidney function that occurs over a few hours or days. It is defined as an increase in the serum creatinine level by 0.3 mg/dL within 48 hours or an increase in the creatinine level to more than 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days, or a urine volume of less than 0.5 mL/kg per hour for six hours.

AKI can be caused by a variety of conditions, including decreased blood flow to the kidneys, obstruction of the urinary tract, exposure to toxic substances, and certain medications. Symptoms of AKI may include decreased urine output, fluid retention, electrolyte imbalances, and metabolic acidosis. Treatment typically involves addressing the underlying cause of the injury and providing supportive care, such as dialysis, to help maintain kidney function until the injury resolves.

... is nonpassage of urine, in practice is defined as passage of less than 100 milliliters of urine in a day. Anuria is ... In males, an enlarged prostate gland is a common cause of obstructive anuria. Acute anuria, where the decline in urine ... Anuria itself is a symptom, not a disease. It is often associated with other symptoms of kidney failure, such as lack of ... "anuria" at Dorland's Medical Dictionary Harrison's Principles of Internal Medicine, 19E PAGE 292 "SUNY Stony Brook Pathology ...
Bowen, WH; Barrett, AM (1946). "A case of anuria". The Clinical Journal. 75: 52-5. PMID 21019000. Barrett, AM; Cole, L (1946 ...
Verbanck, M.; Toussaint, C.; Lieber, C. S.; Lefèvre, A. (1957). "Gastroduodenal bleeding complicating acute anuria during ...
During the summer months, 47 children were admitted to the Jos University teaching hospital, Nigeria, with anuria, fever and ... Soon, patients started to present anuria, acidic breathing, hepatomegaly, and unresponsiveness. Patients were treated with ... and later anuria. Other symptoms reported and secondary to acidosis and/or kidney failure are: hypertension, tachycardia, ...
Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM (July 2001). "Anuria, omphalocele, and perinatal ... Inactivation of the encoding gene in mice leads to anuria, omphalocele and perinatal death. Podocytes are highly differentiated ...
ISBN 978-0-7817-8577-8. Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T, McNagny KM (2001). "Anuria, Omphalocele ...
Severe disease is characterized by pronounced oliguria or anuria, which portends a poor prognosis. It is thought that ...
"Bilateral renal papillary necrosis due to Candida infection in a diabetic patient presenting as anuria". Journal of the ...
Polyuria is a condition of excessive production of urine (> 2.5 L/day), oliguria when < 400 mL are produced, and anuria being ...
... and anuria (< 100 mL/day). The first step in urine formation is the filtration of blood in the kidneys. In a healthy human the ...
Dialysis of the blood (hemodialysis) and peritoneal dialysis can be used to support the kidneys if anuria develops. Oliguria ( ... A negative prognosis has been associated with oliguria or anuria, weakness, difficulty walking, and severe hypercalcemia ( ... with anuria (a lack of urine production). The phenomenon was first identified by the Animal Poison Control Center (APCC), run ...
In severe cases, labial adhesions can cause complete obstruction of the urethra, leading to anuria and urinary retention. The ...
Beyond oliguria is anuria, which represents an absence of urine, clinically classified as below 80 or 100 ml/day. The term ... Polyuria (excessive urine production) Anuria (absolute lack of urine output) Intraabdonmial hypertension (IAH) and Abdominal ...
Symptoms, less likely in chronic obstruction, are pain radiating to the T11 to T12 dermatomes, anuria, nocturia, or polyuria.[ ...
Almost all patients develop oliguria or anuria within a few hours to as late as 6 days post bite. In some cases, kidney ...
Almost all patients develop oliguria or anuria within a few hours to as late as 6 days post bite. In some cases, kidney ...
"The Anurias following Kidney Transplantation", Journal of Internal Medicine, Vol. 148, Issue 2, January/December 1954, pp. 91- ...
Signs and symptoms of ACEi and ARB use during pregnancy include kidney damage or failure, oligohydramnios, anuria, joint ...
... and anuria. The cause of DDS is most commonly (96% of patients) an abnormality in the WT1 gene (Wilms tumor suppressor gene). ...
Commonly reported fetal abnormalities include hypotension, renal dysplasia, anuria/oliguria, oligohydramnios, intrauterine ...
... was temporarily improved but she still died 6 months after the operation from gradually developed cardiac failure and anuria ...
Large amount of excess fluid including: Heart failure Peripheral edema Hypertension Anuria Allergies to sulfa drugs Nausea / ...
... anuria). Conversely, urine concentrations of free light chains could increase if renal function improved in a multiple myeloma ...
... anuria, peripheral neuropathy, and myopathy. No specific antidote for colchicine is known, but supportive care is used in cases ...
... with anuria (a lack of urine production) and may be fatal. Christians have traditionally used wine during worship services as a ...
... anuria (passing less than 50 milliliters of urine in a day), and finally death in the majority of cases.[citation needed] The ...
Oliguria or anuria (decreased or absent urine output) Fatigue Asterixis (flapping tremor) Decreased alertness Confusion Pale ...
... and anuria (when no urine is produced from the kidneys). Not surprisingly, these indicators of shock may be absent in elderly, ...
... of trauma 958.3 Posttraumatic wound infection not elsewhere classified 958.4 Traumatic shock 958.5 Traumatic anuria 958.6 ...
... pain Tenderness Swelling Weakness Bruising Tea colored urine Fever Malaise Nausea Emesis Confusion Agitation Delirium Anuria As ...
Anuria is nonpassage of urine, in practice is defined as passage of less than 100 milliliters of urine in a day. Anuria is ... In males, an enlarged prostate gland is a common cause of obstructive anuria. Acute anuria, where the decline in urine ... Anuria itself is a symptom, not a disease. It is often associated with other symptoms of kidney failure, such as lack of ... "anuria" at Dorlands Medical Dictionary Harrisons Principles of Internal Medicine, 19E PAGE 292 "SUNY Stony Brook Pathology ...
Anuria means nonpassage of urine,[1] in practice is defined as passage of less than 100 milliliters of urine in a day.[2] ... Anuria itself is a symptom, not a disease. It is often associated with other symptoms of kidney failure, such as lack of ... Acute anuria, where the decline in urine production occurs quickly, is usually a sign of obstruction or acute renal failure. ... However, mannitol is contraindicated in anuria secondary to renal disease, severe dehydration, intracranial bleeding (except ...
Actrapid and Anuria. This page shows results related to Actrapid and Anuria from the FDA Adverse Event Reporting System (AERS ...
... we are going to discuss the definitions and causes of both Oilguria and Anuria, which are urinary symptms .What is meant by ... Oliguria and Anuria definition and causes. 30 July 2013 2013-07-30T16:14:00+02:00. 2013-07-30T16:14:11+02:00. Dr.Tamer Mobarak ... Anuria means that urine volume is , 100 ml / 24hrs, it raises the possibility of urinary tract obstruction.. N.B. * 200 ml- 300 ... What is meant by Oliguria and Anuria ?. • Oliguria means Urine output , 400 mL/day (which is the minimal volume of urine which ...
Nausea and vomiting, anuria. 21.0. RBCs, proteinuria, eosinophils. Not performed. Synthetic cannabinoid, not otherwise ...
... pressure monitoring is rarely indicated but may be helpful in patients who have evidence of pulmonary edema or oliguria/anuria. ...
Anuria Montgomery et al reported that severity of symptoms at the time of initial contact with the poison control center ...
Anuria.. The mechanism of nephrotoxicity is thought to be similar to the pathophysiology of liver toxicity: bioactivation by ...
Reports of hypotension, neonatal skull hypoplasia, anuria, reversible or irreversible renal failure, and death owing to ...
Abdominal pain, nausea, anuria. [ ] No follow-up appointment is necessary unless you develop any of the symptoms listed above. ...
Anuria and hypotension.. *Complaints of nausea, weakness, dizziness, and myalgia.. *Hepatic failure, renal failure, ...
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. When pregnancy is ... Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death. When pregnancy is ...
Solution to January 2013 Chronic Quiz: A Case of Anuria. by Amarsinha Nikam ...
Anuria and oliguria. R40.20 - R40.4. Coma. R41.1 - R41.3. Amnesia. R45.0. Nervousness. R51. Headache. ...
A look at anuria, a condition when the kidneys stop production of urine. Included is detail on diagnosis and the potential ...
Frequency not reported: Anuria, urinary retention[Ref]. Psychiatric. Common (1% to 10%): Psychiatric disorders, agitation ...
had dialysis with anuria. *had neurological impairment affecting gait, or. *sensory impairment with the potential to interfere ...
Anuria. • Volume depletion. • Hypernatraemia. • Patients who cannot perceive or respond to thirst ...
Anuria (not able to pass urine) or * Bladder blockage, uncorrected or * Hypovolemic hyponatremia (low blood sodium with low ...
THE CAUSE OF DEATH IN EXPERIMENTAL ANURIA Hebbel E. Hoff, … , Paul K. Smith, Alexander W. Winkler Hebbel E. Hoff, … , Paul K. ...
3. Anuria. 4. 2* to infected hand. There is no evidence of an Accident/Incident Form/Non Conformance form for the 11/11/06 ...
Furosemide Syrup 1% is contraindicated in anuria. Therapy should be discontinued in cases of progressive renal disease if ...
Hypotension, mental status changes, and anuria (late signs). * Hypothermia (often more ominous than fever) ...
Anuria. Sulfonamide allergy.. ZIAC Warnings/Precautions: CHF. Peripheral vascular disease. Bronchospastic disease. Surgery. ...
Kidneys (acute renal failure): oliguria, anuria, azotemia, proteinuria Liver- elevated levels of serum bilirubin, alkaline ...
The most common early indicators of Leptospira infection are: anorexia; polyuria, oliguria, or anuria; lethargy; vomiting; ...
  • Anuria is nonpassage of urine, in practice is defined as passage of less than 100 milliliters of urine in a day. (wikipedia.org)
  • Acute anuria, where the decline in urine production occurs quickly, is usually a sign of obstruction or acute kidney failure. (wikipedia.org)
  • Without functional proximal tubules, the kidneys cannot produce urine (a condition called anuria). (medlineplus.gov)
  • Fetal urine is the major component of the fluid that surrounds the fetus (amniotic fluid), and anuria leads to decreased amniotic fluid levels (oligohydramnios). (medlineplus.gov)
  • Anuria is a condition where the kidney is unable to produce urine. (practo.com)
  • However, mannitol is contraindicated in anuria secondary to renal disease, severe dehydration, intracranial bleeding (except during craniotomy), severe pulmonary congestion, or pulmonary edema. (wikipedia.org)
  • 1). The most common clinical features were conjunctival based investigation found risk factors associated with fatal infection to be older age, hemoptysis, anuria, jaundice, and suffusion and myalgia, followed by abdominal pain and delayed treatment with antimicrobial drugs. (cdc.gov)
  • Univariate analysis showed the following to be in Metro Manila were reported to the Department of Health associated with death: older age, jaundice, anuria, and ( 4 , 5 ). (cdc.gov)
  • In males, an enlarged prostate gland is a common cause of obstructive anuria. (wikipedia.org)
  • Anuria is often caused by failure in the function of kidneys. (wikipedia.org)
  • This page shows results related to Actrapid and Anuria from the FDA Adverse Event Reporting System (AERS). (drugcite.com)
  • Did you mean anuria can be (5,876 results)? (nih.gov)
  • Share your experience with Actrapid and Anuria. (drugcite.com)
  • severe kidney problems such as anuria or progressive and severe oliguria. (news-medical.net)
  • The risk is substantially lower in children who did not require dialysis and in children who were not oliguria or anuric while the risk is the highest in children who had oligo/anuria for more than 7 days. (marlerblog.com)
  • Contraindicated in patients with anuria (absence of urination), liver damage, and hypersensitivity. (medindia.net)
  • Additionally, furosemide injection is contraindicated in patients with anuria, patients with a history of hypersensitivity to furosemide or medical adhesives, and in patients with hepatic cirrhosis or ascites. (hcplive.com)
  • The reasons for admission were dominated by oligo-anuria, digestive disorders, dyspnea and physical asthenia. (scirp.org)
  • The majority of patients consult for oligo-anuria, digestive disorders, dyspnea and physical asthenia. (scirp.org)
  • However, mannitol is contraindicated in anuria secondary to renal disease, severe dehydration, intracranial bleeding (except during craniotomy), severe pulmonary congestion, or pulmonary edema. (wikipedia.org)
  • Acute anuria, where the decline in urine production occurs quickly, is usually a sign of obstruction or acute kidney failure. (wikipedia.org)
  • During the second and third trimesters of pregnancy, these drugs have been associated with fetal injury that includes hypotension, neonatal skull hypoplasia, anuria, reversible or irreversible renal failure, and death. (druglib.com)
  • uria urination urine condition dysuria anuria Commonly caused by renal failure or urinary tract obstruction. (unavignettadipv.it)
  • Absolute insulin deficit alters potassium distribution between the intracellular and extracellular space, and anuria abolishes urinary excretion of potassium. (bioscientifica.com)
  • Its root is used to treat urinary retention and anuria (non-passage of urine). (naturalnews.com)
  • Patients on hemodialysis who develop ketoacidosis may have hyperkalemia because of anuria. (bioscientifica.com)
  • Furosemide Tablets are contraindicated in anuria. (medi-vet.com)
  • Anuria is the complete absence of urine production. (hpathy.com)
  • Is anuria prior to pediatric renal transplantation associated with poor allograft outcomes? (rochester.edu)
  • This medicine is not recommended for use in patients with anuria, a condition where the kidney is unable to produce urine. (practo.com)
  • Anuria is a condition where the kidney is unable to produce urine. (practo.com)